Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.1 (
phosphodiesterase
)
18,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Notch signaling plays an essential role in the proliferation, differentiation and cell fate determination of various tissues, including the developing pancreas. One regulator of the Notch pathway is
GDE2
(or GDPD5), a transmembrane ecto-
phosphodiesterase
that cleaves GPI-anchored proteins at the plasma membrane, including a Notch ligand regulator. Here we report that Gdpd5-knockdown in zebrafish embryos leads to developmental defects, particularly, impaired motility and reduced pancreas differentiation, as shown by decreased expression of insulin and other pancreatic markers. Exogenous expression of human
GDE2
, but not catalytically dead
GDE2
, similarly leads to developmental defects. Human
GDE2
restores insulin expression in Gdpd5a-depleted zebrafish embryos. Importantly, zebrafish Gdpd5 orthologues localize to the plasma membrane where they show catalytic activity against GPI-anchored GPC6. Thus, our data reveal functional conservation between zebrafish Gdpd5 and human
GDE2
, and suggest that strict regulation of
GDE2
expression and catalytic activity is critical for correct embryonic patterning. In particular, our data uncover a role for
GDE2
in regulating pancreas differentiation.
...
PMID:Glycerophosphodiesterase GDE2/GDPD5 affects pancreas differentiation in zebrafish. 2920 33
GDE2
(also known as GDPD5) is a multispanning membrane
phosphodiesterase
with phospholipase D-like activity that cleaves select glycosylphosphatidylinositol (GPI)-anchored proteins and thereby promotes neuronal differentiation both
in vitro
and
in vivo
GDE2
is a prognostic marker in neuroblastoma, while loss of
GDE2
leads to progressive neurodegeneration in mice; however, its regulation remains unclear. Here, we report that, in immature neuronal cells,
GDE2
undergoes constitutive endocytosis and travels back along both fast and slow recycling routes.
GDE2
trafficking is directed by C-terminal tail sequences that determine the ability of
GDE2
to cleave GPI-anchored glypican-6 (GPC6) and induce a neuronal differentiation program. Specifically, we define a
GDE2
truncation mutant that shows aberrant recycling and is dysfunctional, whereas a consecutive deletion results in cell-surface retention and gain of
GDE2
function, thus uncovering distinctive regulatory sequences
.
Moreover, we identify a C-terminal leucine residue in a unique motif that is essential for
GDE2
internalization. These findings establish a mechanistic link between
GDE2
neuronal function and sequence-dependent trafficking, a crucial process gone awry in neurodegenerative diseases.This article has an associated First Person interview with the first author of the paper.
...
PMID:Sequence-dependent trafficking and activity of GDE2, a GPI-specific phospholipase promoting neuronal differentiation. 3193 7